Journal article
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Abstract
BACKGROUND: Whole brain radiotherapy (WBRT) is the standard of care to improve intracranial control following resection of brain metastasis. However, stereotactic radiosurgery (SRS) to the surgical cavity is widely used in an attempt to reduce cognitive toxicity, despite the absence of high-level comparative data substantiating efficacy in the postoperative setting. We aimed to establish the effect of SRS on survival and cognitive outcomes …
Authors
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB
Journal
The Lancet Oncology, Vol. 18, No. 8, pp. 1049–1060
Publisher
Elsevier
Publication Date
August 2017
DOI
10.1016/s1470-2045(17)30441-2
ISSN
1470-2045
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Activities of Daily LivingAdolescentAdultBrain NeoplasmsCognition DisordersDisease ProgressionDisease-Free SurvivalDose Fractionation, RadiationFemaleFollow-Up StudiesHumansIntention to Treat AnalysisMagnetic Resonance ImagingMaleMetastasectomyMiddle AgedNeoplasm Recurrence, LocalQuality of LifeRadiosurgeryRadiotherapy, AdjuvantSurvival RateYoung Adult